活化酸途径减轻了血小板存储损伤,并改善了血小板保存质量
Liujun Guo1, Chengrui Qian2, Chengyan Gao1
1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Blood Transfusion Department, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Thrombosis research
|June 14, 2025
概括
通过调节葡萄糖-6-酸脱酶 (G6PD) 活性,减少了血小板储存病变. 通过酸通路,G6PD维持了血小板线粒体功能,为改善血小板存储提供了目标.
科学领域:
- 血液学 血液学 血液学
- 代谢学 代谢学 代谢学
- 生物化学 生物化学
背景情况:
- 血小板储存损伤 (PSL) 对血小板活力和输血疗效产生负面影响.
- 了解存储期间的血小板代谢变化对于开发干预措施至关重要.
研究的目的:
- 为了研究储存的血小板中的代谢变化.
- 为了确定关键的酶和途径参与血小板储存病变.
- 评估葡萄糖-6-酸盐脱酶 (G6PD) 在存储期间对血小板质量的作用.
主要方法:
- 在不同时间点对存储的血小板进行了非向代谢.
- 进行了G6PD和环氧化原酶-1 (COX-1) 的酶活性测定.
- 流细胞计评估了G6PD和COX-1的药理学操纵后的亡和线粒体功能.
- 血小板聚合试验评估了功能变化.
- 用G6PD淘汰赛小鼠模型来证实这些发现.
主要成果:
- 在储存期间观察到酸 (PPP) 途径,酸和酸代谢的丰富.
- 在早期储存阶段,G6PD活性增加.
- 抑制G6PD导致线粒体损伤,亡增加和聚合受损.
- 在小鼠中,G6PD缺乏导致了恶化的PSLs.
- G6PD激活改善了线粒体功能和血小板聚合.
- 抑制COX-1对PSL指标没有显著影响.
结论:
- 由G6PD调节的酸通路对于维持血小板线粒体完整性至关重要.
- G6PD是缓解血小板储存病变和改善血小板输血质量的关键治疗标.
相关概念视频
01:22Formation of the Platelet Plug
5.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.3K
01:18Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
501
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
501